Vanguard Group Inc Jasper Therapeutics, Inc. Transaction History

Vanguard Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.93 $126,000 - $279,000	300,000 Added 7.91%	4,092,958 $3.23 Million
Q3 2023 Nov 14, 2023	BUY	$0.68 - $1.54 $71,128 - $161,084	104,600 Added 2.84%	3,792,958 $2.66 Million
Q2 2023 Aug 14, 2023	SELL	$1.19 - $1.79 $44,968 - $67,642	-37,789 Reduced 1.01%	3,688,358 $5.05 Million
Q1 2023 May 15, 2023	BUY	$1.48 - $2.74 $4.73 Million - $8.76 Million	3,195,709 Added 602.47%	3,726,147 $6.74 Million
Q4 2022 Feb 10, 2023	BUY	$0.46 - $8.9 $146 - $2,830	318 Added 0.06%	530,438 $254,000
Q3 2022 Nov 14, 2022	BUY	$0.08 - $22.6 $3,964 - $1.12 Million	49,559 Added 10.31%	530,120 $418,000
Q2 2022 Aug 12, 2022	BUY	$1.73 - $3.86 $4,735 - $10,564	2,737 Added 0.57%	480,561 $928,000
Q1 2022 May 13, 2022	SELL	$2.96 - $8.01 $16,809 - $45,488	-5,679 Reduced 1.17%	477,824 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$7.21 - $16.42 $3.49 Million - $7.94 Million	483,503 New	483,503 $3.8 Million

5.63M

Ticker JSPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,073,300
Market Cap $829M
Description
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a techniqu...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.